|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | G01N 33/53 | |
| G01N 33/68 | |||
| A61K 39/395 | |||
| A61P 35/00 | |||
| C12Q 1/68 | |||
| C07K 14/47 | |||
| G01N 33/50 | |||
| C07K 7/06 |
| (11) | Patento numeris | 2569633 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 11781409.5 |
| Europos patento paraiškos padavimo data | 2011-05-16 | |
| (97) | Europos patento paraiškos paskelbimo data | 2013-03-20 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2016-02-10 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2011/036665 |
| Data | 2011-05-16 |
| (87) | Numeris | WO 2011/143656 |
| Data | 2011-11-17 |
| (30) | Numeris | Data | Šalis |
| 334866 P | 2010-05-14 | US |
| (72) |
HACOHEN, Nir, US
WU, Catherine, US
|
| (73) |
The General Hospital Corporation,
55 Fruit Street, Boston, MA 02114,
US
Dana-Farber Cancer Institute, Inc., 450 Brookline Avenue, Boston, MA 02215, US |
| (54) | COMPOSITIONS AND METHODS OF IDENTIFYING TUMOR SPECIFIC NEOANTIGENS |
| COMPOSITIONS AND METHODS OF IDENTIFYING TUMOR SPECIFIC NEOANTIGENS |